HIV 1 News and Research

RSS

FDA announces new label for HIV antiviral drug Invirase

The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when used with Norvir (ritonavir), another HIV antiviral medication.

22 Oct 2010

Indian, S. African leaders call for developing countries to work together, invest more in science

India's Prime Minister Manmohan Singh on Tuesday during the launch of the Third World Academy of Sciences meeting (TWAS) in Hyderabad, India, called for developing countries to place greater emphasis on scientific research and application, the Economic Times reports.

22 Oct 2010

CIHR, RX&D - HRF to fund research projects on mental illness, palliative care

Six research projects on co-existing heath problems associated with mental illness and one project on palliative care among First Nations received over $9 million in funding announced today. This amount is provided by the Canadian Institutes of Health Research and the Rx&D Health Research Foundation.

22 Oct 2010

NIH awards three new SBIR grants to Taiga

Taiga Biotechnologies, Inc. today announced that the company has received three new Small Business Innovation Research (SBIR) grants from the National Institutes of Health, totaling $1.7 million. This adds to the two previous grants awarded to Taiga for various applications of its proprietary technology platforms, for a total in NIH funding to date of over $2.1 million.

22 Oct 2010

UCLA researchers receive NIH grant to study HIV-positive men from LA County jails

A team of UCLA researchers has received a $4.6 million grant from the National Institutes of Health to study ways to get HIV-positive men who have been released from Los Angeles County jails into medical care and on sustained treatment.

22 Oct 2010

Clinical research scholar receives grant to promote lifestyle changes for HIV patients

Between the demands of work, family and friends, many women find health takes a back seat. Women with HIV are no exception. "Many women with the HIV face challenges from sleepless nights to little personal time-all activities that can negatively impact health," says Allison Webel, a clinical research scholar and instructor at the Frances Payne Bolton School of Nursing at Case Western Reserve University.

22 Oct 2010

SciDev.Net examines plans for India-S. Africa HIV vaccine research project

SciDev.Net reports on an HIV vaccine research collaboration between researchers from India and South Africa to launch by the end of 2010.

21 Oct 2010

Study on health effects of alcohol consumption with HIV

Living with HIV is difficult under the best of circumstances, but for people carrying the virus, alcohol consumption can become particularly perilous in intricate ways that are only beginning to be understood. At the Brown Alcohol Research Center on HIV (ARCH) funded by a new $7.5-million, five-year grant from the National Institutes of Health, Brown University scientists will study the health effects of drinking with HIV and provide doctors and patients with the latest guidance their results suggest.

21 Oct 2010

NIH awards $7 million grant to provide sustained care for HIV-positive inmates

The University of Illinois at Chicago has received a $7 million grant from the National Institutes of Health to study effective ways to seek, test, and treat inmates with HIV.

21 Oct 2010

Also in Global Health News: Foreign aid in Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health in Myanmar; Poverty in Zambia; Rwanda's progress on MDGs; Men involved in PMTCT of HIV

Ethiopia's government has been restricting access to food and other types of foreign aid among opposition supporters, Human Rights Watch (HRW) said in a report on Tuesday, Reuters reports (Malone, 10/19). The report is based on more than 200 interviews, conducted over a six-month period in 2009, of people in 53 villages across three regions of the country, according to an HRW press release (10/19).

21 Oct 2010

LANL's researcher to implement first human trial of mosaic HIV vaccine candidate

Los Alamos National Laboratory researcher Bette Korber is part of an international team of investigators working to design and implement the first human trial of a mosaic HIV vaccine candidate. The vaccine represents a novel strategy for fighting the virus that causes AIDS by attempting to address one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity.

20 Oct 2010

AU launches African women's decade project to improve health, development

Delegates from around the world attended the launch of the African Women's Decade, 2010-2020, (AWD) at an event in Nairobi, Kenya, on Friday, the Kenya Broadcasting Corporation reports.

20 Oct 2010

Gilead Sciences third quarter total revenues increase 8% to $1.94 billion

Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.

20 Oct 2010

Opinions: Mdgs in Africa; development maintenance; U.S. efforts to eradicate polio; Global Fund commitment

Addressing the Millennium Development Goals (MDGs) in Africa will not only require extra spending, but also better spending, as well as the improvement of social services and priority setting, Kingsley Alu writes in a Leadership column.

20 Oct 2010

HIV/AIDS status grim in Australia: Experts

Reports show that most Australians are complacent about getting AIDS. They feel that unless a person is homosexual or an injecting drug user or a sex worker, they are not at risk.

19 Oct 2010

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Johnson & Johnson today announced sales of $15.0 billion for the third quarter of 2010, a decrease of 0.7% as compared to the third quarter of 2009. Operational results increased 0.1% and the negative impact of currency was 0.8%. Domestic sales declined 2.5%, while international sales increased 1.1%, reflecting operational growth of 2.6% and a negative currency impact of 1.5%.

19 Oct 2010

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).

19 Oct 2010

Government Officials, U.N. Staff meet with sex workers in Asia to examine access to HIV services

In parts of Asia, policies outlawing sex work are undermining HIV/AIDS prevention efforts by fragmenting and stigmatizing the sex workers and turning condom possession into an act that could lead to jail time, NGO officials say, IRIN reports.

19 Oct 2010

New research coalition to design first human trial of mosaic HIV vaccine candidate

Duke University Medical Center vaccine experts have assembled an international team of investigators to design and implement the first human trial of a mosaic HIV vaccine candidate, a novel strategy that attempts to counter one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity

19 Oct 2010

Micronics to advance PanNAT system for molecular diagnosis of infectious pathogens

Micronics, Inc., a development-stage company, today announced that the Department of Defense has awarded the company an Applied Research and Technology Development Award under the U.S. Army Medical Research and Materiel Command's Polytrauma and Blast Injury project for advancement of its PanNAT system for point-of-care molecular diagnosis of infectious pathogens.

19 Oct 2010

HIV 1 News and Research

FDA announces new label for HIV antiviral drug Invirase

Indian, S. African leaders call for developing countries to work together, invest more in science

CIHR, RX&D - HRF to fund research projects on mental illness, palliative care

NIH awards three new SBIR grants to Taiga

UCLA researchers receive NIH grant to study HIV-positive men from LA County jails

Clinical research scholar receives grant to promote lifestyle changes for HIV patients

SciDev.Net examines plans for India-S. Africa HIV vaccine research project

Study on health effects of alcohol consumption with HIV

NIH awards $7 million grant to provide sustained care for HIV-positive inmates

Also in Global Health News: Foreign aid in Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health in Myanmar; Poverty in Zambia; Rwanda's progress on MDGs; Men involved in PMTCT of HIV

LANL's researcher to implement first human trial of mosaic HIV vaccine candidate

AU launches African women's decade project to improve health, development

Gilead Sciences third quarter total revenues increase 8% to $1.94 billion

Opinions: Mdgs in Africa; development maintenance; U.S. efforts to eradicate polio; Global Fund commitment

HIV/AIDS status grim in Australia: Experts

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Government Officials, U.N. Staff meet with sex workers in Asia to examine access to HIV services

New research coalition to design first human trial of mosaic HIV vaccine candidate

Micronics to advance PanNAT system for molecular diagnosis of infectious pathogens

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News